Enfuvirtide: all 30 studies that test it
Page 1 of 1. Open to participants first (0), then studies with results posted, then the rest; newest registration first within each.
- A Study of Enfuvirtide (Fuzeon) in Participants With Advanced Human Immunodeficiency Virus (HIV) InfectionCompletedNCT02582983Phase 4Results posted
- Optimizing Treatment for Treatment-Experienced, HIV-Infected PeopleCompletedNCT00537394Phase 3Results posted
- A Study to Evaluate the Safety and Efficacy of Adding Enfuvirtide to Oral Highly Active Antiretroviral Therapy (HAART) in Human Immunodeficiency Virus (HIV) Patients With Prior Treatment ExperienceCompletedNCT00487188Phase 4Results posted
- BLQ Study: A Study of a Protease Inhibitor With Fuzeon (Enfuvirtide) in Treatment-Experienced Patients With HIV-1.CompletedNCT00326963Phase 4Results posted
- T-20 Plus a Selected Anti-HIV Treatment in HIV-Infected Children and AdolescentsCompletedNCT00022763Phase 2Results posted
- Efficacy, and Safety Study of Optimized Background Antiretroviral Regimen (OB) in Combination With Enfuvirtide in the Treatment-Experienced Participants With Human Immunodeficiency Virus-1 (HIV-1) InfectionCompletedNCT02733419Phase 3
- A Study of Enfuvirtide (Fuzeon) in Patients With Advanced Human Immunodeficiency Virus-1 (HIV-1) InfectionCompletedNCT02569502Phase 4
- Optimized Antiretroviral Therapy During Allogeneic Hematopoietic Stem Cell Transplantation in HIV-1 IndividualsCompletedNCT01836068Early Phase 1
- Metabolic Effects of Enfuvirtide in Healthy VolunteersCompletedNCT00657761Phase 4
- INNOVE Study: A Study of 3 Months Induction With Fuzeon (Enfuvirtide) + Optimized Background (OB) Versus OB Alone in HIV-1 Infected Patients With Virological Failure.CompletedNCT00615134Phase 2
- Clinical Trial to Assess the Efficacy of Darunavir/Ritonavir (DRV/r), Etravirine (ETV) and Raltegravir (MK-0518) in HIV Patients With Resistant VirusesCompletedNCT00460382Phase 2
- A Study to Evaluate of the Efficacy of Enfuvirtide During the Induction Phase of TherapyCompletedNCT00344760Phase 4
- BOSS Study: A Study of Fuzeon Using the Needle-Free Biojector 2000 in Patients With HIV-1 InfectionCompletedNCT00337701Phase 4
- Fuzeon Viral Decay Pilot StudyCompletedNCT00334022Not applicable
- Study of Valproic Acid to Treat HIV Infected AdultsTerminatedNCT00312546Phase 1
- Intensification With Enfuvirtide in Naive HIV-infected Patients (ANRS130)CompletedNCT00302822Phase 3
- WAND Study - A Study to Evaluate Fuzeon (Enfuvirtide) Administered by a Needle-Free Injection Device in Patients With HIV.CompletedNCT00233883Phase 4
- QUALITE Study - A Study of Fuzeon (Enfuvirtide) in Treatment-Experienced Patients With Human Immunodeficiency Virus-1 (HIV-1) InfectionCompletedNCT00232908Phase 4
- Early Intensification of Antiretroviral Therapy Including Enfuvirtide in HIV-1-Related Progressive Multifocal Leucoencephalopathy (ANRS125)CompletedNCT00120367Phase 2
- Treatment Intensification for HIV Infected Patients With Multi-Drug Resistant VirusStatus unknownNCT00102934Not applicable
- A 48 Week Study Comparing Treatment With Saquinavir + Lopinavir/Ritonavir in Combination With Enfuvirtide HAART Versus Saquinavir + Lopinavir/Ritonavir + Other Nucleoside Combinations to See the Efficacy of These Treatments in Patients Infected With HIV-1TerminatedNCT00100984Phase 4
- A Study Comparing the Efficacy and Safety of Once-Daily Fuzeon (Enfuvirtide) Dosing Versus the Currently Recommended Twice-Daily Dosing in Human Immunodeficiency Virus-Type 1 (HIV-1) Infected PatientsCompletedNCT00089492Phase 2
- Study of Enfuvirtide in HIV-Positive SubjectsCompletedNCT00086710Phase 1
- Effect of an Enfuvirtide-based Anti-HIV Drug Regimen on Latent HIV Reservoirs in Treatment Naive AdultsCompletedNCT00051831Not applicable
- Adding New Drugs for HIV Infected Patients Failing Current TherapyCompletedNCT00031044Phase 1/2
- T-20 in HIV Patients With Prior Drug Treatment and/or Resistance to Each of the Three Classes of Anti-HIV DrugsCompletedNCT00021554Phase 3
- HIV Maintenance Therapy With T-20 During HAART InterruptionCompletedNCT00013884Phase 2
- T-20 With Anti-HIV Combination Therapy for Patients With Prior Anti-HIV Drug Treatment and/or Drug Resistance to Each of the Three Classes of Approved Anti-HIV DrugsCompletedNCT00008528Phase 3
- A Study of T-20 in HIV-Positive AdultsCompletedNCT00002228Phase 2
- Study of a New Anti-HIV Drug, T-20, in HIV-Infected ChildrenCompletedNCT00001118Phase 1